Search results for "Hospital costs"

showing 10 items of 16 documents

Healthcare resource utilization and costs of nonalcoholic steatohepatitis patients with advanced liver disease in Italy

2020

Abstract Background and aims Nonalcoholic steatohepatitis (NASH) may progress to advanced liver disease (AdvLD). This study characterized comorbidities, healthcare resource utilization (HCRU) and associated costs among hospitalized patients with AdvLD due to NASH in Italy. Methods and results Adult nonalcoholic fatty liver disease (NAFLD)/NASH patients from 2011 to 2017 were identified from administrative databases of Italian local health units using ICD-9-CM codes. Development of compensated cirrhosis (CC), decompensated cirrhosis (DCC), hepatocellular carcinoma (HCC), or liver transplant (LT) was identified using first diagnosis date for each severity cohort (index-date). Patients progres…

Liver CirrhosisMaleTime FactorsCirrhosisDatabases FactualEndocrinology Diabetes and MetabolismMedicine (miscellaneous)ComorbidityHospital Cost030204 cardiovascular system & hematologyLiver diseasePatient Admission0302 clinical medicineRetrospective StudieNon-alcoholic Fatty Liver DiseaseRisk FactorsNonalcoholic fatty liver diseaseAmbulatory CarePrevalenceMedicineHospital Costseducation.field_of_studyDrug CostNutrition and DieteticsLiver NeoplasmsNASHMiddle AgedPrognosisItalyLiver NeoplasmHepatocellular carcinomaCohortDisease ProgressionHealth ResourcesFemaleCardiology and Cardiovascular MedicineHumanAdultmedicine.medical_specialtyCarcinoma HepatocellularTime FactorAdolescentCostPrognosiLiver CirrhosiPopulation030209 endocrinology & metabolismPharmacyDrug CostsYoung Adult03 medical and health sciencesNAFLDInternal medicineHumanseducationAgedRetrospective StudiesHealth Resourcebusiness.industryRisk Factormedicine.diseaseComorbiditydigestive system diseasesLiver TransplantationHCRUbusinessAdministrative Claims HealthcareNutrition, Metabolism and Cardiovascular Diseases
researchProduct

Surgeon volume and hospital volume in endocrine neck surgery: how many procedures are needed for reaching a safety level and acceptable costs? A syst…

2018

The relationship between quality of care and provider's experience is well known in all fields of surgery. Even in thyroidectomies and parathyroidectomies, the emphasis on positive volume-outcome relationships is believed. It led us to an evaluation of volume activity's impact in terms of quality of care. A systematic narrative review was performed. According to the PRISMA criteria, we selected 87 paper and, after the study selection was performed, 22 studies were finally included in this review. All articles included were unanimous in attributing to activity volume of surgeons as well as centers a substantial importance. Some differences in outcomes between these investigated categories ha…

Reoperationmedicine.medical_specialtyHospitals Low-VolumeCost-Benefit Analysismedicine.medical_treatmentOperative TimeMEDLINEReview030230 surgery03 medical and health sciencesPostoperative Complications0302 clinical medicineHospital volumemedicineHumansHospital CostsQuality of careendocrine surgerySurgeon volumeParathyroidectomySurgeonsbusiness.industryLength of StaySingle surgeonSurgeryEndocrine surgery030220 oncology & carcinogenesisThyroidectomyNarrative reviewbusinessHospital stayHospitals High-VolumeProcedures and Techniques Utilization
researchProduct

What is the impact of rerouting a cancer diagnosis from emergency presentation to GP referral on resource use and survival? Evidence from a populatio…

2018

Background Studies on alternative routes to diagnosis stimulated successful policy interventions reducing the number of emergency diagnoses and associated mortality risk. A dearth of evidence on the costs of such interventions might prevent new policies from achieving more ambitious targets. Methods We conducted a retrospective cohort study on the population of colorectal (88,051), breast (90,387), prostate (96,219), and lung (97,696) cancer patients diagnosed after a GP referral or an emergency presentation and reported in the Cancer Registry of England. Resource use and survival were compared 1 year before and 5 years after diagnosis (3 years for lung), including the costs of GP referrals…

Emergency Medical ServicesCancer ResearchSurvival0302 clinical medicineNeoplasmsEmergency medical services1306030212 general & internal medicineMedical diagnosisReferral and Consultationeducation.field_of_study1311Health Care CostsEarly diagnosilcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensPrognosisEarly diagnosisPrimary careRoute to diagnosisRoute to diagnosiOncologyPopulation Surveillance030220 oncology & carcinogenesisHealth ResourcesHospital costResearch Articlemedicine.medical_specialty2730ReferralEarly diagnosis; Emergency; Hospital costs; Primary care; Route to diagnosis; Survival; Oncology; Genetics; Cancer ResearchPopulationlcsh:RC254-28203 medical and health sciencesGeneticGeneral PractitionersGeneticsmedicineHumanseducationLung cancerbusiness.industryCancerRetrospective cohort studymedicine.diseaseCancer registryEmergency medicineEmergencyHospital costsbusinessNeoplasms/diagnosis
researchProduct

Hospitalisation Cost of Patients with Diabetic Foot Ulcers in Valencia (Spain) in the Period 2009–2013: A Retrospective Descriptive Analysis

2018

Ulcers are the main cause of hospitalisation and clinical complications in patients with diabetes. We analyse the length and cost of hospital stay of patients with diabetic foot ulcers, taking into consideration that hospitalisation and, if necessary, amputation represent the greatest area of expense to the healthcare system for such patients. This analysis focuses on the treatment provided to these patients in public hospitals in the region of Valencia (Spain), registered in the Spanish Minimum Basic Data Set, during the period 2009&ndash

Malemedicine.medical_specialtyCostHealth Toxicology and Mutagenesismedicine.medical_treatmentcostslcsh:Medicine030209 endocrinology & metabolismÚlceresArticle03 medical and health sciences0302 clinical medicineMBDS (Minimum Basic Data Set)Diabetes mellitusmedicineHumansIn patient030212 general & internal medicineHospital CostsulcersSocioeconomic statusAgedRetrospective StudiesDiabetisDescriptive statisticsbusiness.industrylcsh:RPublic Health Environmental and Occupational HealthMiddle Agedmedicine.diseaseDiabetic footDiabetic FootHospitalsHospitalizationAmputationSpainEmergency medicineFemalebusinessHospital staydiabetic footHealthcare systemInternational Journal of Environmental Research and Public Health
researchProduct

Early rehabilitation of cancer patients - a randomized controlled intervention study.

2013

Published version of an article in the journal: BMC Cancer. Also available from the publisher at: http://dx.doi.org/10.1186/1471-2407-13-9 Open access Background: Faced with a life-threatening illness, such as cancer, many patients develop stress symptoms, i.e. avoidance behaviour, intrusive thoughts and worry. Stress management interventions have proven to be effective; however, they are mostly performed in group settings and it is commonly breast cancer patients who are studied. We hereby present the design of a randomized controlled trial (RCT) evaluating the effectiveness and cost-effectiveness of an individual stress-management intervention with a stepped-care approach in several cance…

Research designCounselingMaleCancer ResearchMedicin och hälsovetenskapTime Factorsmedicine.medical_treatmentCost-Benefit AnalysisAnxietyVDP::Medisinske fag: 700::Klinisk medisinske fag: 750::Onkologi: 762Medical and Health Scienceslaw.inventionStress Disorders Post-TraumaticStudy ProtocolRandomized controlled trialCost of IllnesslawNeoplasmsSurveys and QuestionnairesActivities of Daily LivingAdaptation PsychologicalLongitudinal StudiesProspective StudiesHospital CostsIndividual stress managementProspective cohort studyFatiguemedia_commonDepressionAdjuvant/curative therapyVDP::Medical disciplines: 700::Health sciences: 800lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensMental HealthTreatment OutcomeOncologyResearch DesignVDP::Midical sciences: 700::Clinical medical sciences: 750::Oncology: 762FemaleWorryMental Health ServicesSleep Wake Disordersmedicine.medical_specialtyImpact of event scalePsychometricsmedia_common.quotation_subjectMotor Activitylcsh:RC254-282Breast cancerIntervention (counseling)GeneticsmedicineHumansRCT with stepped-care approachMotivationCognitive Behavioral Therapybusiness.industryPhysical activityCancermedicine.diseasePhysical therapyCognitive therapyQuality of LifebusinessSleepStress PsychologicalBMC cancer
researchProduct

Epidemiology and social costs of hip fracture.

2018

Hip fracture is an important and debilitating condition in older people, particularly in women. The epidemiological data varies between countries, but it is globally estimated that hip fractures will affect around 18% of women and 6% of men. Although the age-standardised incidence is gradually falling in many countries, this is far outweighed by the ageing of the population. Thus, the global number of hip fractures is expected to increase from 1.26 million in 1990 to 4.5 million by the year 2050. The direct costs associated with this condition are enormous since it requires a long period of hospitalisation and subsequent rehabilitation. Furthermore, hip fracture is associated with the devel…

medicine.medical_specialtyFinancing PersonalPopulationDisease03 medical and health sciencesIndirect costs0302 clinical medicineAge DistributionEpidemiologyMedicineHumans030212 general & internal medicineHospital CostseducationDepression (differential diagnoses)General Environmental Science030222 orthopedicseducation.field_of_studyHip fracturebusiness.industryHip FracturesIncidence (epidemiology)IncidenceLength of Staymedicine.diseaseHospitalizationSarcopeniaQuality of LifeGeneral Earth and Planetary SciencesbusinessHip fracture Social cost EpidemiologyDemographyInjury
researchProduct

The Hip Fracture Surgery in Elderly Patients (HIPELD) study: protocol for a randomized, multicenter controlled trial evaluating the effect of xenon o…

2012

Trials 13, 180 (2012). doi:10.1186/1745-6215-13-180

Time FactorsXenonCost-Benefit AnalysisMedicine (miscellaneous)Hospital CostHip fracturelaw.inventionStudy ProtocolFracture Fixation InternalRandomized controlled triallawFracture fixationAge FactorPharmacology (medical)Prospective StudiesHospital CostsProspective cohort studylcsh:R5-920Hip fractureDrug CostIncidence (epidemiology)Age FactorsPostoperative deliriumPsychiatric Status Rating ScaleEuropeTreatment OutcomeResearch DesignAnesthesiaAnesthetics Inhalationmedicine.symptomlcsh:Medicine (General)Humanmedicine.drugMethyl Ethersmedicine.medical_specialtyTime FactorDrug CostsSevofluraneSevofluranemedicineHumansCost-Benefit AnalysiAgedPsychiatric Status Rating ScalesHip Fracturesbusiness.industryDeliriummedicine.diseaseSurgeryClinical trialProspective StudieMethyl EtherDeliriumbusinessTrials
researchProduct

Evaluation économique de la prématurité : une première année de vie aux enjeux majeurs : le cas de la France

2016

This thesis focuses on a first economic assessment of prematurity in France. Prematurity is defined as occurring before 37 weeks of gestation. It is increasing in France and worldwide. If the issues of public health are already well identified, medical care and collective choices concerning prematurity matters also involve significant economic challenges. The first part of this thesis attempts to present the public health issues of prematurity and highlights the remaining efforts required to provide prevention in France. It then considers economic issues on the use of socially fairer resources dedicated to perinatal health in a context where current health expenditure is rising. Assessment …

PréventionSNIIRAMCoûts extrahospitaliersGestational ageAnalyse économique[SHS.ECO]Humanities and Social Sciences/Economics and FinanceCoûts hospitaliersEconomic analysesAge gestationnel[ SHS.ECO ] Humanities and Social Sciences/Economies and financesNon-hospital costs[SHS.ECO] Humanities and Social Sciences/Economics and FinanceHospital costsPrematurityPrématurité
researchProduct

Are we really seeing the total costs of surgical site infections? A Spanish study.

2007

To identify overall costs generated by surgical site infections (SSI) patients, including indirect costs. A prospective study of case series of patients who have undergone major surgical treatment was undertaken. Patients who suffered SSI were compared with controls (nested case-control design). Centers for Disease Control and Prevention definitions were followed and SSI established. Overall costs and indirect related morbidity/mortality costs were estimated. The study was performed in a general, tertiary hospital (Valencia, Spain) for 4.5 years. Surgical site infections patients were 9.02% of the total people who underwent surgery. Their stays were prolonging by 14 days, and resources were…

medicine.medical_specialtyTotal costbusiness.industryDermatologyLength of Staymedicine.diseaseDisease controlIndirect costsCost of IllnessSpainEmergency medicineHealth careSurgical siteCost of illnessmedicineHumansSurgical Wound InfectionSurgeryMedical emergencyHospital CostsbusinessSurgical treatmentProspective cohort studyhealth care economics and organizationsWound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society
researchProduct

Severe third molar complications including death-lessons from 100 cases requiring hospitalization.

2006

Purpose In this study we investigated patients that were hospitalized due to third molar (M3) complications. Specifically we analyzed frequency, age distribution, and outcome with respect to the M3 clinical status. Patients and Methods We set up a prospective cohort study and included 100 subjects admitted for management of acute M3-associated complications. The clinical status of the M3 was defined as 1 ) prophylactic M3 removal, 2 ) therapeutic (nonelective) M3 removal, or 3 ) M3 present at the time of admission. Outcome variables were clinical infection markers (C-reactive protein, leukocyte counts) and economic parameters (treatment costs, length of hospital stay, and days of disability…

MolarAdultMalemedicine.medical_specialtyPericoronitisAdolescentMyocardial InfarctionLeukocyte CountsStatistics NonparametricLeukocyte CountFatal OutcomeCost of IllnessGermanySickness Impact ProfilemedicineHumansSurgical Wound InfectionMyocardial infarctionProspective StudiesHospital CostsProspective cohort studyAgedAged 80 and overbusiness.industryLength of StayMiddle Agedmedicine.diseaseProphylactic SurgerySurgeryC-Reactive ProteinOtorhinolaryngologyTooth ExtractionSurgeryObservational studyFemaleMolar ThirdPericoronitisOral SurgeryComplicationbusinessJournal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons
researchProduct